Guggenheim initiated coverage of Insmed with a Buy rating and $50 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on INSM:
- Insmed management to meet with Cantor Fitgerald
- Insmed announces inducement grants under NASDAQ listing rule
Questions or Comments about the article? Write to editor@tipranks.com